CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 282 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,431 | +235.1% | 20,404 | +40.7% | 0.15% | +255.8% |
| Q3 2023 | $427 | -16.4% | 14,500 | -7.5% | 0.04% | -32.8% |
| Q2 2023 | $511 | -63.3% | 15,678 | -48.4% | 0.06% | -54.0% |
| Q4 2022 | $1,392 | -99.8% | 30,390 | +104.1% | 0.14% | +95.8% |
| Q3 2022 | $721,000 | +219.0% | 14,889 | +158.5% | 0.07% | +173.1% |
| Q2 2022 | $226,000 | -31.7% | 5,760 | -65.6% | 0.03% | -21.2% |
| Q2 2021 | $331,000 | -29.9% | 16,749 | -23.2% | 0.03% | -56.6% |
| Q3 2020 | $472,000 | +137.2% | 21,795 | +16.0% | 0.08% | +137.5% |
| Q4 2019 | $199,000 | +12.4% | 18,795 | +28.7% | 0.03% | -3.0% |
| Q2 2017 | $177,000 | +20.4% | 14,602 | +20.7% | 0.03% | -15.4% |
| Q4 2016 | $147,000 | – | 12,102 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |